Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
The top clinical trial opportunities in therapeutic apheresis and neurology.
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis.
A nexus between lipids and multiple sclerosis?
Restless Legs Syndrome in Multiple Sclerosis.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
Pregnancy and multiple sclerosis.
Evidence for a multiple sclerosis epidemic?
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
[Neuropathology of multiple sclerosis].
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
CXCL13 antibody for the treatment of autoimmune disorders.
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis.
Diffusion restriction of the optic nerve in patients with acute visual deficit.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Pages
« first
‹ previous
…
364
365
366
367
368
369
370
371
372
…
next ›
last »